That stomach acid can wear down tooth enamel fast
Cardillo C, Kilcoyne CM, Cannon III RO, Quyyumi AA, Panza JA
Ganju and coauthors commented, Defining the role of GLP-1 RAs in Crohns disease is critical as obesity prevalence rises and integrated care models across gastroenterology, endocrinology, and obesity medicine become more essential. This study included 546 patients with CD with overweight or obesity who had initiated use of a GLP-1RA and were matched with 546 nonGLP-1RA users from the TriNetX research network
Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F
Each peptide has a different purpose and should be selected based on your health goals
Wegovy (semaglutide injection, 2.4 mg) is FDA-approved for chronic weight management in adults with obesity, or overweight adults with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
